| 1 |
33271294 | Aldosterone synthase inhibitors for cardiovascular diseases: A comprehensive review of preclinical, clinical and in silico data. | 2021 Jan |
3 |
| 2 |
30425102 | Structure of human cortisol-producing cytochrome P450 11B1 bound to the breast cancer drug fadrozole provides insights for drug design. | 2019 Jan 11 |
2 |
| 3 |
28759940 | Impact of Aldosterone Synthase Inhibitor FAD286 on Steroid Hormone Profile in Human Adrenocortical Cells. | 2017 Sep |
4 |
| 4 |
23322723 | Structural insights into aldosterone synthase substrate specificity and targeted inhibition. | 2013 Feb |
2 |
| 5 |
23856493 | Role of brain corticosterone and aldosterone in central angiotensin II-induced hypertension. | 2013 Sep |
1 |
| 6 |
19622340 | Coexpression of CYP11B2 or CYP11B1 with adrenodoxin and adrenodoxin reductase for assessing the potency and selectivity of aldosterone synthase inhibitors. | 2009 Nov 1 |
2 |
| 7 |
16685193 | Can the dextroenantiomer of the aromatase inhibitor fadrozole be useful for clinical investigation of aldosterone-synthase inhibition? | 2006 Jun |
2 |
| 8 |
15985365 | The adrenocortical tumor cell line NCI-H295R as an in vitro screening system for the evaluation of CYP11B2 (aldosterone synthase) and CYP11B1 (steroid-11beta-hydroxylase) inhibitors. | 2005 Aug |
1 |